Write your own CDx success story

CDx Boston reveals the most exciting clinical and commercial results and addresses the most pressing challenges facing CDx development right now, with the world’s leading drug and Dx developers.

More and more drug developers are seeking to achieve successful and effective companion diagnostic development to cement their position in the ‘personalized’ future. High profile collaborations with Dx companies have been key in advancing the field in recent years. But there are still questions around what makes a successful companion diagnostic development strategy. For example…

How to reduce clinical attrition by using biomarkers and the latest technology platforms more effectively?

How to overcome market access hurdles in the face of regulatory and reimbursement uncertainty?

and of course how to  form the most effective partnerships, in order to share risk, increase chances of success and get to market faster?

World CDx Boston brings you exclusive insights, novel case studies and cutting-edge solutions from those at the forefront of personalized medicine. This unique collection of industry leaders will address the most pressing challenges, both at lab-phase and at market level. You will leave the meeting with the tools and knowledge you need to reduce clinical attrition, achieve successful commercialization and claim your place as a CDx market leader, now.

Why attend World CDx Boston?

1. Increase your clinical efficacy

• Hear the latest, most exciting case studies from industry leaders representing Pfizer, Merrimack, BMS, Merck, Genentech, Daiichi Sankyo, Astellas, J&J and Abbott
• Improve your biomarker transition strategies with examples from Regeneron and Biogen Idec
• Coordinate biomarkers for lower attrition rates and CDx success by listening to experts from Merck, Genentech and Ventana
•  Hear the latest work being carried out in research institutes and in the clinic and learn how this will affect your CDx development. Harvard, Moffitt and NIH will present their results

“This was a great conference with outstanding speakers. They gave an up to date view of all aspects and issues concerning companion Dx development” Transgene

“Expertise from thought leaders is rarely so freely given, or as earnestly debated” CHI Center for Translational Research

2. Get to market faster

• Over 15 hours of dedicated commercial presentations. Exclusive real world Insights from QIAGEN, Abbott Molecular and Boston Healthcare Associates give you an outstanding overview of how you can optimize your market access pathways for companion diagnostics
• Concerned by regulatory hurdles? Hear Erling Donnelly, Director of Worldwide Regulatory Strategy at Pfizer tell the Xalkori story, and learn how to create stronger integrated approval strategies for your targeted therapies
• Unclear about current reimbursement paradigms for diagnostics? Discuss payment policy with experts from Casdin Capital, AdvaMedDx and Generation Health, and find out the best ways of capturing value and achieving ROI
• Attend the interactive, solution led workshops and come away with the tools you need to develop, launch, and implement companion diagnostics in a highly competitive commercial landscape

"A valuable resource for learning from case studies and keeping up with current policies and regulations. Also a great opportunity for connecting the needs of biotech and pharma with diagnostic companies" Merrimack

3. Maximize the effectiveness of your partnership

• Practical exclusive case studies from both sides of the pharmacodiagnostic partnership. Peter Collins of GlaxoSmithKline talks about the gold standard in diagnostic partner selection and David Jackson of PrimeraDx speaks on building a culture of communication and sharing, moving beyond the ‘fee-for-service’ dynamic
• The perfect balance of attendees from pharma and Dx, to enable the most effective partnership conversations. With over 80% of attendees made up of C-level, Director and VP decision makers 
• Take away practical information on partnership excellence from the presentations, increase your knowledge and then apply to your onsite discussions, during the dedicated networking time. World CDx Boston provides you with the tools you need to build the optimal CDx co-development partnership, and then puts you in front of your potential partners.

“High quality attendees generates a good opportunity to network” Abbott